Is there an alternative to alternating adjuvant therapy for breast cancer?
Hudis
C
C
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans
D000970:Antineoplastic Agents